20 research outputs found
El rol de la enfermera en la cadena transfusional en época de pandemia
La única manera de asegurar la terapia transfusional es mediante las donaciones regulares de hemodonantes. Actualmente las donaciones y las transfusiones, son seguras pero no están exentas ni de riesgo ni de factores que alteren estos procedimientos, por lo que se necesitará una enfermera cualificada que ejerza sus funciones de forma competente.Objetivos: El objetivo de este trabajo es realizar una revisión bibliográfica que permita conocer el rol que desempeña la enfermera a lo largo de la cadena transfusional.Como aportación novedosa a esta revisión, se agrupa las funciones de enfermería que este profesional desarrolla en la cadena transfusional recopiladas en base a la bibliografía revisada y que podrían ampliar la percepción del profesional de enfermería sobre la terapia transfusional , que es algo más que administrar sangre así como los cuidados irremplazables que la enfermera proporciona antes, durante y después de la terapia transfusional.<br /
Electrochemical oxidation of butyl paraben on boron doped diamond in environmental matrices and comparison with sulfate radical-AOP
The electrochemical oxidation (EO) of butyl paraben (BP) over boron-doped diamond (BDD) anode was studied in this work. Emphasis was put on degradation performance in various actual water matrices, including secondary treated wastewater (WW), bottled water (BW), surface water (SW), ultrapure water (UW), and ultrapure water spiked with humic acid (HA). Experiments were performed utilizing 0.1 M Na2SO4 as the electrolyte. Interestingly, matrix complexity was found to favor BP degradation, i.e. in the order WW ~ BW > SW > UW, thus implying some kind of synergy between the water matrix constituents, the reactive oxygen species (ROS) and the anode surface. The occurrence of chloride in water matrices favors reaction presumably due to the formation of chlorine-based oxidative species, and this can partially offset the need to work at increased current densities in the case of chlorine-free electrolytes. No pH effect in the range 3–8 on degradation was recorded. EO oxidation was also compared with a sulfate radical process using carbon black as activator of sodium persulfate. The matrix effect was, in this case, detrimental (i.e. UW > BW > WW), pinpointing the different behavior of different processes in similar environments
Influencia de la presencia de sólidos en la eliminación de cianuros en efluentes industriales mediante fotocatálisis con TiO2
Los cianuros se detectan en aguas residuales industriales las cuales deben ser tratadas previamente a su vertido al cauce receptor. Los tratamientos de eliminación de cianuros a partir de procesos avanzados de oxidación mediante la combinación de agentes como el ozono, el peróxido de hidrógeno, el dióxido de titanio y la luz ultravioleta pueden verse afectados por diferentes especies presentes en la matriz
Screening of CACNA1A and ATP1A2 genes in hemiplegic migraine: clinical, genetic and functional studies
Hemiplegic migraine (HM) is a rare and severe subtype of autosomal dominant migraine, characterized by a complex aura including some degree of motor weakness. Mutations in four genes (CACNA1A, ATP1A2, SCN1A and PRRT2) have been detected in familial and in sporadic cases. This genetically and clinically heterogeneous disorder is often accompanied by permanent ataxia, epileptic seizures, mental retardation, and chronic progressive cerebellar atrophy. Here we report a mutation screening in the CACNA1A and ATP1A2 genes in 18 patients with HM. Furthermore, intragenic copy number variant (CNV) analysis was performed in CACNA1A using quantitative approaches. We identified four previously described missense CACNA1A mutations (p.Ser218Leu, p.Thr501Met, p.Arg583Gln, and p.Thr666Met) and two missense changes in the ATP1A2 gene, the previously described p.Ala606Thr and the novel variant p.Glu825Lys. No structural variants were found. This genetic screening allowed the identification of more than 30% of the disease alleles, all present in a heterozygous state. Functional consequences of the CACNA1A-p.Thr501Met mutation, previously described only in association with episodic ataxia, and ATP1A2-p.Glu825Lys, were investigated by means of electrophysiological studies, cell viability assays or Western blot analysis. Our data suggest that both these variants are disease-causing
8.10. Efecto de las partículas de carbón en la remoción fotocatalítica de cianuro usando TiO2.
Mutation Spectrum in the CACNA1A Gene in 49 Patients with Episodic Ataxia
Episodic ataxia is an autosomal dominant ion channel disorder characterized by episodes of imbalance and incoordination. The disease is genetically heterogeneous and is classified as episodic ataxia type 2 (EA2) when it is caused by a mutation in the CACNA1A gene, encoding the α1A subunit of the P/Q-type voltage-gated calcium channel Cav2.1. The vast majority of EA2 disease-causing variants are loss-of-function (LoF) point changes leading to decreased channel currents. CACNA1A exonic deletions have also been reported in EA2 using quantitative approaches. We performed a mutational screening of the CACNA1A gene, including the promoter and 3'UTR regions, in 49 unrelated patients diagnosed with episodic ataxia. When pathogenic variants were not found by sequencing, we performed a copy number variant (CNV) analysis to screen for duplications or deletions. Overall, sequencing screening allowed identification of six different point variants (three nonsense and three missense changes) and two coding indels, one of them found in two unrelated patients. Additionally, CNV analysis identified a deletion in a patient spanning exon 35 as a result of a recombination event between flanking intronic Alu sequences. This study allowed identification of potentially pathogenic alterations in our sample, five of them novel, which cover 20% of the patients (10/49). Our data suggest that most of these variants are disease-causing, although functional studies are required.The funding for this study was provided by the Spanish Ministerio de Economía y Competitividad (SAF2009-13182-C01, SAF2009-13182-C03), AGAUR (2014SGR-0932, 2009SGR-0078) and Fundació La Marató de TV3 (grant 100731). These institutions had no further role in study design, collection, analysis, interpretation of data or in the submission of this paper for publication. CS and OC were supported by Ministerio de Economía y Competitividad (BES-2007-16450 and BES-2010-033895, respectively) and NF-C by Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER, ISCIII). MV-P was supported by a predoctoral grant from VHIR, Barcelona (Spain). CT was supported by the European Union (Marie Curie, PIEF-GA-2009-254930). EC-L is the recipient of the Beatriu de Pinós programme scholarship (BP-DGR 2010)
Mutation spectrum in the CACNA1A gene in 49 patients with episodic ataxia
Episodic ataxia is an autosomal dominant ion channel disorder characterized by episodes of imbalance and incoordination. The disease is genetically heterogeneous and is classified as episodic ataxia type 2 (EA2) when it is caused by a mutation in the CACNA1A gene, encoding the α1A subunit of the P/Q-type voltage-gated calcium channel Cav2.1. The vast majority of EA2 disease-causing variants are loss-of-function (LoF) point changes leading to decreased channel currents. CACNA1A exonic deletions have also been reported in EA2 using quantitative approaches. We performed a mutational screening of the CACNA1A gene, including the promoter and 3′UTR regions, in 49 unrelated patients diagnosed with episodic ataxia. When pathogenic variants were not found by sequencing, we performed a copy number variant (CNV) analysis to screen for duplications or deletions. Overall, sequencing screening allowed identification of six different point variants (three nonsense and three missense changes) and two coding indels, one of them found in two unrelated patients. Additionally, CNV analysis identified a deletion in a patient spanning exon 35 as a result of a recombination event between flanking intronic Alu sequences. This study allowed identification of potentially pathogenic alterations in our sample, five of them novel, which cover 20% of the patients (10/49). Our data suggest that most of these variants are disease-causing, although functional studies are required
Mutation spectrum in the CACNA1A gene in 49 patients with episodic ataxia
Episodic ataxia is an autosomal dominant ion channel disorder characterized by episodes of imbalance and incoordination. The disease is genetically heterogeneous and is classified as episodic ataxia type 2 (EA2) when it is caused by a mutation in the CACNA1A gene, encoding the α1A subunit of the P/Q-type voltage-gated calcium channel Cav2.1. The vast majority of EA2 disease-causing variants are loss-of-function (LoF) point changes leading to decreased channel currents. CACNA1A exonic deletions have also been reported in EA2 using quantitative approaches. We performed a mutational screening of the CACNA1A gene, including the promoter and 3′UTR regions, in 49 unrelated patients diagnosed with episodic ataxia. When pathogenic variants were not found by sequencing, we performed a copy number variant (CNV) analysis to screen for duplications or deletions. Overall, sequencing screening allowed identification of six different point variants (three nonsense and three missense changes) and two coding indels, one of them found in two unrelated patients. Additionally, CNV analysis identified a deletion in a patient spanning exon 35 as a result of a recombination event between flanking intronic Alu sequences. This study allowed identification of potentially pathogenic alterations in our sample, five of them novel, which cover 20% of the patients (10/49). Our data suggest that most of these variants are disease-causing, although functional studies are required
Mutation spectrum in the CACNA1A gene in 49 patients with episodic ataxia
Episodic ataxia is an autosomal dominant ion channel disorder characterized by episodes of imbalance and incoordination. The disease is genetically heterogeneous and is classified as episodic ataxia type 2 (EA2) when it is caused by a mutation in the CACNA1A gene, encoding the α1A subunit of the P/Q-type voltage-gated calcium channel Cav2.1. The vast majority of EA2 disease-causing variants are loss-of-function (LoF) point changes leading to decreased channel currents. CACNA1A exonic deletions have also been reported in EA2 using quantitative approaches. We performed a mutational screening of the CACNA1A gene, including the promoter and 3′UTR regions, in 49 unrelated patients diagnosed with episodic ataxia. When pathogenic variants were not found by sequencing, we performed a copy number variant (CNV) analysis to screen for duplications or deletions. Overall, sequencing screening allowed identification of six different point variants (three nonsense and three missense changes) and two coding indels, one of them found in two unrelated patients. Additionally, CNV analysis identified a deletion in a patient spanning exon 35 as a result of a recombination event between flanking intronic Alu sequences. This study allowed identification of potentially pathogenic alterations in our sample, five of them novel, which cover 20% of the patients (10/49). Our data suggest that most of these variants are disease-causing, although functional studies are required